Cleared Traditional

K980759 - DIAMEDIX IS-ENA-6 SCREEN TEST SYSTEM

K980759 is an FDA 510(k) clearance for DIAMEDIX IS-ENA-6 SCREEN TEST SYSTEM, manufactured by Diamedix Corp.. The device is a Class 2 Immunology device with product code LLL cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K980759 · Diamedix Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1998
Decision
55d
Days
Class 2
Risk

K980759 is an FDA 510(k) clearance for the DIAMEDIX IS-ENA-6 SCREEN TEST SYSTEM. Classified as Extractable Antinuclear Antibody, Antigen And Control (product code LLL), Class II - Special Controls.

Submitted by Diamedix Corp. (Miami, US). The FDA issued a Cleared decision on April 23, 1998 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diamedix Corp. devices

FDA 510(k) Submission Details - K980759

510(k) Number K980759 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 1998
Decision Date April 23, 1998
Days to Decision 55 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 105d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLL Device Classification - Class 2, Special Controls

Product Code LLL Extractable Antinuclear Antibody, Antigen And Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LLL Extractable Antinuclear Antibody, Antigen And Control

All 143
Devices cleared under the same product code (LLL) and FDA review panel - the closest regulatory comparables to K980759.
EL-ANA PROFILES: EL-ENA/5
K982622 · Theratest Laboratories, Inc. · Aug 1998
QUANTA LITE TPO ELISA
K981857 · Inova Diagnostics, Inc. · Jul 1998
SERAQUEST ANTI-SSB
K980639 · Quest Intl., Inc. · Jun 1998
MARDX ENA IGG IMMUNOSTRIPE TEST SYSTEM / MARDX ENA IGG MARSTRIPE TEST SYSTEM
K964787 · Mardx Diagnostics, Inc. · Apr 1997
IS-ANTI-SSA TEST SYSTEM
K970218 · Diamedix Corp. · Apr 1997
IS-ANTI-SM TEST SYSTEM
K970220 · Diamedix Corp. · Apr 1997